pharmaobservatory 0.1.4 → 0.1.6

This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
Files changed (325) hide show
  1. checksums.yaml +4 -4
  2. data/README.md +118 -7
  3. data/docs/ApiV1WhoamiGet200Response.md +13 -1
  4. data/docs/ApiV1WhoamiGet200ResponseLimits.md +32 -0
  5. data/docs/ApiV1WhoamiGet200ResponseQuota.md +20 -0
  6. data/docs/ApiV1WhoamiGet200ResponseQuotaBuckets.md +28 -0
  7. data/docs/ApiV1WhoamiGet200ResponseQuotaBucketsRequestsPerMinute.md +28 -0
  8. data/docs/BiomarkerAssayEvidenceResponse.md +58 -0
  9. data/docs/{BiomarkerCdxAssertionsResponseBuild.md → BiomarkerAssayEvidenceResponseBuild.md} +2 -2
  10. data/docs/{BiomarkerCdxAssertionsResponseFreshness.md → BiomarkerAssayEvidenceResponseFreshness.md} +2 -2
  11. data/docs/{BiomarkerCdxAssertionsResponseScope.md → BiomarkerAssayEvidenceResponseScope.md} +2 -2
  12. data/docs/BiomarkerAssayEvidenceRow.md +68 -0
  13. data/docs/BiomarkerAssayWhitespaceResponse.md +58 -0
  14. data/docs/BiomarkerAssayWhitespaceRow.md +66 -0
  15. data/docs/BiomarkerBqpAssertionsResponse.md +3 -3
  16. data/docs/BiomarkerCdxAssertionsResponse.md +3 -3
  17. data/docs/BiomarkerEvidenceResponse.md +3 -3
  18. data/docs/BiomarkerLiteratureResponse.md +3 -3
  19. data/docs/BiomarkerPublishingCompaniesResponse.md +3 -3
  20. data/docs/BiomarkerPublishingCompaniesRow.md +9 -1
  21. data/docs/BiomarkerRelationsResponse.md +3 -3
  22. data/docs/BiomarkerSampleCoverageResponse.md +3 -3
  23. data/docs/BiomarkerSamplePrevalenceResponse.md +3 -3
  24. data/docs/BiomarkerValidationResponse.md +3 -3
  25. data/docs/BiomarkerVariantMentionsResponse.md +3 -3
  26. data/docs/BiomarkersApi.md +160 -0
  27. data/docs/BiomarkersRecord.md +2 -2
  28. data/docs/BiomarkersResponse.md +3 -3
  29. data/docs/BiomarkersRow.md +2 -0
  30. data/docs/CellLinesRecord.md +2 -2
  31. data/docs/CellLinesResponse.md +3 -3
  32. data/docs/CompaniesApi.md +246 -0
  33. data/docs/CompaniesRecord.md +2 -2
  34. data/docs/CompaniesResponse.md +3 -3
  35. data/docs/CompaniesRow.md +1 -1
  36. data/docs/CompanyAssetsResponse.md +3 -3
  37. data/docs/CompanyFundingEventsResponse.md +3 -3
  38. data/docs/CompanyFundingEventsRow.md +1 -1
  39. data/docs/CompanyFundingSummaryResponse.md +3 -3
  40. data/docs/CompanyMembersResponse.md +3 -3
  41. data/docs/CompanyProgramsResponse.md +3 -3
  42. data/docs/CompanyTargetsResponse.md +3 -3
  43. data/docs/CompanyTargetsRow.md +5 -1
  44. data/docs/ConditionAdverseEventsResponse.md +3 -3
  45. data/docs/ConditionBurdenResponse.md +3 -3
  46. data/docs/ConditionDeliveryResponse.md +3 -3
  47. data/docs/ConditionDrugsResponse.md +3 -3
  48. data/docs/ConditionPrevalenceResponse.md +3 -3
  49. data/docs/ConditionPrevalenceRow.md +1 -1
  50. data/docs/ConditionPublicationsResponse.md +3 -3
  51. data/docs/ConditionRecruitmentByPhaseResponse.md +58 -0
  52. data/docs/ConditionRecruitmentByPhaseRow.md +50 -0
  53. data/docs/ConditionRecruitmentDurationResponse.md +58 -0
  54. data/docs/ConditionRecruitmentDurationRow.md +86 -0
  55. data/docs/ConditionSitesResponse.md +3 -3
  56. data/docs/ConditionTrialStartForecastResponse.md +58 -0
  57. data/docs/ConditionTrialStartForecastRow.md +70 -0
  58. data/docs/ConditionTrialsResponse.md +3 -3
  59. data/docs/ConditionTrialsRow.md +4 -2
  60. data/docs/ConditionsApi.md +240 -0
  61. data/docs/ConditionsRecord.md +2 -2
  62. data/docs/ConditionsRecordAttributes.md +3 -1
  63. data/docs/ConditionsResponse.md +3 -3
  64. data/docs/DrugPatentCliffResponse.md +3 -3
  65. data/docs/InstitutionalHoldingsResponse.md +3 -3
  66. data/docs/InstitutionalHoldingsRow.md +7 -1
  67. data/docs/InvestorFundsResponse.md +58 -0
  68. data/docs/InvestorFundsRow.md +24 -0
  69. data/docs/InvestorPortfolioResponse.md +58 -0
  70. data/docs/InvestorPortfolioRow.md +42 -0
  71. data/docs/InvestorPrivateFundsResponse.md +58 -0
  72. data/docs/InvestorPrivateFundsRow.md +44 -0
  73. data/docs/InvestorsApi.md +633 -0
  74. data/docs/InvestorsRecord.md +38 -0
  75. data/docs/InvestorsResponse.md +58 -0
  76. data/docs/InvestorsRow.md +54 -0
  77. data/docs/LegalEntitiesApi.md +240 -0
  78. data/docs/LegalEntitiesRecord.md +2 -2
  79. data/docs/LegalEntitiesResponse.md +3 -3
  80. data/docs/LegalEntitiesRow.md +1 -1
  81. data/docs/ManagersApi.md +233 -0
  82. data/docs/ManagersRecord.md +38 -0
  83. data/docs/ManagersResponse.md +58 -0
  84. data/docs/ManagersRow.md +46 -0
  85. data/docs/OrgDisclosuresResponse.md +58 -0
  86. data/docs/OrgDisclosuresRow.md +56 -0
  87. data/docs/OrgRelationshipsResponse.md +58 -0
  88. data/docs/OrgRelationshipsRow.md +68 -0
  89. data/docs/OwnershipPositionsResponse.md +3 -3
  90. data/docs/OwnershipPositionsRow.md +16 -14
  91. data/docs/PdufaDatesResponse.md +3 -3
  92. data/docs/SiteBedsYearlyResponse.md +3 -3
  93. data/docs/SiteCroTrialsResponse.md +3 -3
  94. data/docs/SiteHospitalsResponse.md +3 -3
  95. data/docs/SiteInvestigatorsResponse.md +3 -3
  96. data/docs/SiteTrialConditionsResponse.md +3 -3
  97. data/docs/SiteTrialDrugsResponse.md +3 -3
  98. data/docs/SiteTrialsResponse.md +3 -3
  99. data/docs/SiteTrialsRow.md +3 -1
  100. data/docs/SitesRecord.md +2 -2
  101. data/docs/SitesResponse.md +3 -3
  102. data/docs/SponsorRecruitmentByPhaseResponse.md +3 -3
  103. data/docs/SponsorRecruitmentDurationResponse.md +3 -3
  104. data/docs/SponsorTrialStartForecastResponse.md +3 -3
  105. data/docs/SponsorTrialsResponse.md +3 -3
  106. data/docs/SponsorTrialsRow.md +4 -2
  107. data/docs/SupplierCapabilityEsgResponse.md +58 -0
  108. data/docs/SupplierCapabilityEsgRow.md +64 -0
  109. data/docs/SupplierServicesResponse.md +58 -0
  110. data/docs/SupplierServicesRow.md +30 -0
  111. data/docs/SupplierSitesResponse.md +58 -0
  112. data/docs/SupplierSitesRow.md +42 -0
  113. data/docs/SuppliersApi.md +313 -0
  114. data/docs/SuppliersRecord.md +38 -0
  115. data/docs/SuppliersResponse.md +58 -0
  116. data/docs/SuppliersRow.md +76 -0
  117. data/docs/TargetAssociationsResponse.md +58 -0
  118. data/docs/TargetAssociationsRow.md +26 -0
  119. data/docs/TargetCrowdingResponse.md +58 -0
  120. data/docs/TargetCrowdingRow.md +30 -0
  121. data/docs/TargetDrugsResponse.md +58 -0
  122. data/docs/TargetDrugsRow.md +38 -0
  123. data/docs/TargetEvidenceResponse.md +58 -0
  124. data/docs/TargetEvidenceRow.md +52 -0
  125. data/docs/TargetPatentMentionsResponse.md +58 -0
  126. data/docs/TargetPatentMentionsRow.md +34 -0
  127. data/docs/TargetProgramsResponse.md +58 -0
  128. data/docs/TargetProgramsRow.md +58 -0
  129. data/docs/TargetPublicationsResponse.md +58 -0
  130. data/docs/TargetPublicationsRow.md +32 -0
  131. data/docs/TargetRegulatoryPrecedentResponse.md +58 -0
  132. data/docs/TargetRegulatoryPrecedentRow.md +38 -0
  133. data/docs/TargetTrialsResponse.md +58 -0
  134. data/docs/TargetTrialsRow.md +46 -0
  135. data/docs/TargetsApi.md +1033 -0
  136. data/docs/TargetsRecord.md +38 -0
  137. data/docs/TargetsResponse.md +58 -0
  138. data/docs/TargetsRow.md +68 -0
  139. data/docs/TrialAdverseEventsResponse.md +3 -3
  140. data/docs/TrialChangesResponse.md +3 -3
  141. data/docs/TrialDeliveryResponse.md +3 -3
  142. data/docs/TrialDeliveryRow.md +7 -5
  143. data/docs/TrialDemographicsResponse.md +3 -3
  144. data/docs/TrialDrugClassesResponse.md +58 -0
  145. data/docs/TrialDrugClassesRow.md +28 -0
  146. data/docs/TrialDrugsResponse.md +3 -3
  147. data/docs/TrialEnrollmentHistoryResponse.md +3 -3
  148. data/docs/TrialEnrollmentRateResponse.md +3 -3
  149. data/docs/TrialEnrollmentRateRow.md +5 -3
  150. data/docs/TrialExtractedEndpointsResponse.md +3 -3
  151. data/docs/TrialKolsResponse.md +58 -0
  152. data/docs/TrialKolsRow.md +32 -0
  153. data/docs/TrialOutcomeMeasuresResponse.md +3 -3
  154. data/docs/TrialResearchPaymentsResponse.md +58 -0
  155. data/docs/TrialResearchPaymentsRow.md +44 -0
  156. data/docs/TrialSiteHistoryResponse.md +58 -0
  157. data/docs/TrialSiteHistoryRow.md +50 -0
  158. data/docs/TrialSitesResponse.md +3 -3
  159. data/docs/TrialsApi.md +320 -0
  160. data/docs/TrialsRecord.md +2 -2
  161. data/docs/TrialsResponse.md +3 -3
  162. data/docs/TrialsRow.md +3 -3
  163. data/lib/pharmaobservatory/api/biomarkers_api.rb +168 -0
  164. data/lib/pharmaobservatory/api/companies_api.rb +273 -0
  165. data/lib/pharmaobservatory/api/conditions_api.rb +252 -0
  166. data/lib/pharmaobservatory/api/investors_api.rb +665 -0
  167. data/lib/pharmaobservatory/api/legal_entities_api.rb +252 -0
  168. data/lib/pharmaobservatory/api/managers_api.rb +245 -0
  169. data/lib/pharmaobservatory/api/suppliers_api.rb +329 -0
  170. data/lib/pharmaobservatory/api/targets_api.rb +1085 -0
  171. data/lib/pharmaobservatory/api/trials_api.rb +336 -0
  172. data/lib/pharmaobservatory/models/api_v1_whoami_get200_response.rb +62 -4
  173. data/lib/pharmaobservatory/models/api_v1_whoami_get200_response_limits.rb +419 -0
  174. data/lib/pharmaobservatory/models/api_v1_whoami_get200_response_quota.rb +263 -0
  175. data/lib/pharmaobservatory/models/api_v1_whoami_get200_response_quota_buckets.rb +367 -0
  176. data/lib/pharmaobservatory/models/api_v1_whoami_get200_response_quota_buckets_requests_per_minute.rb +367 -0
  177. data/lib/pharmaobservatory/models/biomarker_assay_evidence_response.rb +478 -0
  178. data/lib/pharmaobservatory/models/{biomarker_cdx_assertions_response_build.rb → biomarker_assay_evidence_response_build.rb} +3 -3
  179. data/lib/pharmaobservatory/models/{biomarker_cdx_assertions_response_freshness.rb → biomarker_assay_evidence_response_freshness.rb} +3 -3
  180. data/lib/pharmaobservatory/models/{biomarker_cdx_assertions_response_scope.rb → biomarker_assay_evidence_response_scope.rb} +3 -3
  181. data/lib/pharmaobservatory/models/biomarker_assay_evidence_row.rb +506 -0
  182. data/lib/pharmaobservatory/models/biomarker_assay_whitespace_response.rb +478 -0
  183. data/lib/pharmaobservatory/models/biomarker_assay_whitespace_row.rb +499 -0
  184. data/lib/pharmaobservatory/models/biomarker_bqp_assertions_response.rb +3 -3
  185. data/lib/pharmaobservatory/models/biomarker_cdx_assertions_response.rb +3 -3
  186. data/lib/pharmaobservatory/models/biomarker_evidence_response.rb +3 -3
  187. data/lib/pharmaobservatory/models/biomarker_literature_response.rb +3 -3
  188. data/lib/pharmaobservatory/models/biomarker_publishing_companies_response.rb +3 -3
  189. data/lib/pharmaobservatory/models/biomarker_publishing_companies_row.rb +49 -5
  190. data/lib/pharmaobservatory/models/biomarker_relations_response.rb +3 -3
  191. data/lib/pharmaobservatory/models/biomarker_sample_coverage_response.rb +3 -3
  192. data/lib/pharmaobservatory/models/biomarker_sample_prevalence_response.rb +3 -3
  193. data/lib/pharmaobservatory/models/biomarker_validation_response.rb +3 -3
  194. data/lib/pharmaobservatory/models/biomarker_variant_mentions_response.rb +3 -3
  195. data/lib/pharmaobservatory/models/biomarkers_record.rb +2 -2
  196. data/lib/pharmaobservatory/models/biomarkers_response.rb +3 -3
  197. data/lib/pharmaobservatory/models/biomarkers_row.rb +12 -1
  198. data/lib/pharmaobservatory/models/cell_lines_record.rb +2 -2
  199. data/lib/pharmaobservatory/models/cell_lines_response.rb +3 -3
  200. data/lib/pharmaobservatory/models/companies_record.rb +2 -2
  201. data/lib/pharmaobservatory/models/companies_response.rb +3 -3
  202. data/lib/pharmaobservatory/models/companies_row.rb +1 -1
  203. data/lib/pharmaobservatory/models/company_assets_response.rb +3 -3
  204. data/lib/pharmaobservatory/models/company_funding_events_response.rb +3 -3
  205. data/lib/pharmaobservatory/models/company_funding_events_row.rb +1 -1
  206. data/lib/pharmaobservatory/models/company_funding_summary_response.rb +3 -3
  207. data/lib/pharmaobservatory/models/company_members_response.rb +3 -3
  208. data/lib/pharmaobservatory/models/company_programs_response.rb +3 -3
  209. data/lib/pharmaobservatory/models/company_targets_response.rb +3 -3
  210. data/lib/pharmaobservatory/models/company_targets_row.rb +27 -5
  211. data/lib/pharmaobservatory/models/condition_adverse_events_response.rb +3 -3
  212. data/lib/pharmaobservatory/models/condition_burden_response.rb +3 -3
  213. data/lib/pharmaobservatory/models/condition_delivery_response.rb +3 -3
  214. data/lib/pharmaobservatory/models/condition_drugs_response.rb +3 -3
  215. data/lib/pharmaobservatory/models/condition_prevalence_response.rb +3 -3
  216. data/lib/pharmaobservatory/models/condition_prevalence_row.rb +1 -1
  217. data/lib/pharmaobservatory/models/condition_publications_response.rb +3 -3
  218. data/lib/pharmaobservatory/models/condition_recruitment_by_phase_response.rb +478 -0
  219. data/lib/pharmaobservatory/models/condition_recruitment_by_phase_row.rb +399 -0
  220. data/lib/pharmaobservatory/models/condition_recruitment_duration_response.rb +478 -0
  221. data/lib/pharmaobservatory/models/condition_recruitment_duration_row.rb +597 -0
  222. data/lib/pharmaobservatory/models/condition_sites_response.rb +3 -3
  223. data/lib/pharmaobservatory/models/condition_trial_start_forecast_response.rb +478 -0
  224. data/lib/pharmaobservatory/models/condition_trial_start_forecast_row.rb +509 -0
  225. data/lib/pharmaobservatory/models/condition_trials_response.rb +3 -3
  226. data/lib/pharmaobservatory/models/condition_trials_row.rb +14 -3
  227. data/lib/pharmaobservatory/models/conditions_record.rb +2 -2
  228. data/lib/pharmaobservatory/models/conditions_record_attributes.rb +13 -4
  229. data/lib/pharmaobservatory/models/conditions_response.rb +3 -3
  230. data/lib/pharmaobservatory/models/drug_patent_cliff_response.rb +3 -3
  231. data/lib/pharmaobservatory/models/institutional_holdings_response.rb +3 -3
  232. data/lib/pharmaobservatory/models/institutional_holdings_row.rb +35 -2
  233. data/lib/pharmaobservatory/models/investor_funds_response.rb +478 -0
  234. data/lib/pharmaobservatory/models/investor_funds_row.rb +256 -0
  235. data/lib/pharmaobservatory/models/investor_portfolio_response.rb +478 -0
  236. data/lib/pharmaobservatory/models/investor_portfolio_row.rb +357 -0
  237. data/lib/pharmaobservatory/models/investor_private_funds_response.rb +478 -0
  238. data/lib/pharmaobservatory/models/investor_private_funds_row.rb +366 -0
  239. data/lib/pharmaobservatory/models/investors_record.rb +385 -0
  240. data/lib/pharmaobservatory/models/investors_response.rb +478 -0
  241. data/lib/pharmaobservatory/models/investors_row.rb +421 -0
  242. data/lib/pharmaobservatory/models/legal_entities_record.rb +2 -2
  243. data/lib/pharmaobservatory/models/legal_entities_response.rb +3 -3
  244. data/lib/pharmaobservatory/models/legal_entities_row.rb +1 -1
  245. data/lib/pharmaobservatory/models/managers_record.rb +385 -0
  246. data/lib/pharmaobservatory/models/managers_response.rb +478 -0
  247. data/lib/pharmaobservatory/models/managers_row.rb +377 -0
  248. data/lib/pharmaobservatory/models/org_disclosures_response.rb +478 -0
  249. data/lib/pharmaobservatory/models/org_disclosures_row.rb +432 -0
  250. data/lib/pharmaobservatory/models/org_relationships_response.rb +478 -0
  251. data/lib/pharmaobservatory/models/org_relationships_row.rb +498 -0
  252. data/lib/pharmaobservatory/models/ownership_positions_response.rb +3 -3
  253. data/lib/pharmaobservatory/models/ownership_positions_row.rb +26 -15
  254. data/lib/pharmaobservatory/models/pdufa_dates_response.rb +3 -3
  255. data/lib/pharmaobservatory/models/site_beds_yearly_response.rb +3 -3
  256. data/lib/pharmaobservatory/models/site_cro_trials_response.rb +3 -3
  257. data/lib/pharmaobservatory/models/site_hospitals_response.rb +3 -3
  258. data/lib/pharmaobservatory/models/site_investigators_response.rb +3 -3
  259. data/lib/pharmaobservatory/models/site_trial_conditions_response.rb +3 -3
  260. data/lib/pharmaobservatory/models/site_trial_drugs_response.rb +3 -3
  261. data/lib/pharmaobservatory/models/site_trials_response.rb +3 -3
  262. data/lib/pharmaobservatory/models/site_trials_row.rb +13 -2
  263. data/lib/pharmaobservatory/models/sites_record.rb +2 -2
  264. data/lib/pharmaobservatory/models/sites_response.rb +3 -3
  265. data/lib/pharmaobservatory/models/sponsor_recruitment_by_phase_response.rb +3 -3
  266. data/lib/pharmaobservatory/models/sponsor_recruitment_duration_response.rb +3 -3
  267. data/lib/pharmaobservatory/models/sponsor_trial_start_forecast_response.rb +3 -3
  268. data/lib/pharmaobservatory/models/sponsor_trials_response.rb +3 -3
  269. data/lib/pharmaobservatory/models/sponsor_trials_row.rb +14 -3
  270. data/lib/pharmaobservatory/models/supplier_capability_esg_response.rb +478 -0
  271. data/lib/pharmaobservatory/models/supplier_capability_esg_row.rb +480 -0
  272. data/lib/pharmaobservatory/models/supplier_services_response.rb +478 -0
  273. data/lib/pharmaobservatory/models/supplier_services_row.rb +289 -0
  274. data/lib/pharmaobservatory/models/supplier_sites_response.rb +478 -0
  275. data/lib/pharmaobservatory/models/supplier_sites_row.rb +357 -0
  276. data/lib/pharmaobservatory/models/suppliers_record.rb +385 -0
  277. data/lib/pharmaobservatory/models/suppliers_response.rb +478 -0
  278. data/lib/pharmaobservatory/models/suppliers_row.rb +544 -0
  279. data/lib/pharmaobservatory/models/target_associations_response.rb +478 -0
  280. data/lib/pharmaobservatory/models/target_associations_row.rb +267 -0
  281. data/lib/pharmaobservatory/models/target_crowding_response.rb +478 -0
  282. data/lib/pharmaobservatory/models/target_crowding_row.rb +289 -0
  283. data/lib/pharmaobservatory/models/target_drugs_response.rb +478 -0
  284. data/lib/pharmaobservatory/models/target_drugs_row.rb +335 -0
  285. data/lib/pharmaobservatory/models/target_evidence_response.rb +478 -0
  286. data/lib/pharmaobservatory/models/target_evidence_row.rb +410 -0
  287. data/lib/pharmaobservatory/models/target_patent_mentions_response.rb +478 -0
  288. data/lib/pharmaobservatory/models/target_patent_mentions_row.rb +311 -0
  289. data/lib/pharmaobservatory/models/target_programs_response.rb +478 -0
  290. data/lib/pharmaobservatory/models/target_programs_row.rb +447 -0
  291. data/lib/pharmaobservatory/models/target_publications_response.rb +478 -0
  292. data/lib/pharmaobservatory/models/target_publications_row.rb +300 -0
  293. data/lib/pharmaobservatory/models/target_regulatory_precedent_response.rb +478 -0
  294. data/lib/pharmaobservatory/models/target_regulatory_precedent_row.rb +333 -0
  295. data/lib/pharmaobservatory/models/target_trials_response.rb +478 -0
  296. data/lib/pharmaobservatory/models/target_trials_row.rb +377 -0
  297. data/lib/pharmaobservatory/models/targets_record.rb +385 -0
  298. data/lib/pharmaobservatory/models/targets_response.rb +478 -0
  299. data/lib/pharmaobservatory/models/targets_row.rb +498 -0
  300. data/lib/pharmaobservatory/models/trial_adverse_events_response.rb +3 -3
  301. data/lib/pharmaobservatory/models/trial_changes_response.rb +3 -3
  302. data/lib/pharmaobservatory/models/trial_delivery_response.rb +3 -3
  303. data/lib/pharmaobservatory/models/trial_delivery_row.rb +22 -11
  304. data/lib/pharmaobservatory/models/trial_demographics_response.rb +3 -3
  305. data/lib/pharmaobservatory/models/trial_drug_classes_response.rb +478 -0
  306. data/lib/pharmaobservatory/models/trial_drug_classes_row.rb +278 -0
  307. data/lib/pharmaobservatory/models/trial_drugs_response.rb +3 -3
  308. data/lib/pharmaobservatory/models/trial_enrollment_history_response.rb +3 -3
  309. data/lib/pharmaobservatory/models/trial_enrollment_rate_response.rb +3 -3
  310. data/lib/pharmaobservatory/models/trial_enrollment_rate_row.rb +15 -4
  311. data/lib/pharmaobservatory/models/trial_extracted_endpoints_response.rb +3 -3
  312. data/lib/pharmaobservatory/models/trial_kols_response.rb +478 -0
  313. data/lib/pharmaobservatory/models/trial_kols_row.rb +302 -0
  314. data/lib/pharmaobservatory/models/trial_outcome_measures_response.rb +3 -3
  315. data/lib/pharmaobservatory/models/trial_research_payments_response.rb +478 -0
  316. data/lib/pharmaobservatory/models/trial_research_payments_row.rb +366 -0
  317. data/lib/pharmaobservatory/models/trial_site_history_response.rb +478 -0
  318. data/lib/pharmaobservatory/models/trial_site_history_row.rb +401 -0
  319. data/lib/pharmaobservatory/models/trial_sites_response.rb +3 -3
  320. data/lib/pharmaobservatory/models/trials_record.rb +2 -2
  321. data/lib/pharmaobservatory/models/trials_response.rb +3 -3
  322. data/lib/pharmaobservatory/models/trials_row.rb +3 -3
  323. data/lib/pharmaobservatory/version.rb +1 -1
  324. data/lib/pharmaobservatory.rb +75 -3
  325. metadata +152 -8
@@ -0,0 +1,38 @@
1
+ # PharmaObservatory::TargetRegulatoryPrecedentRow
2
+
3
+ ## Properties
4
+
5
+ | Name | Type | Description | Notes |
6
+ | ---- | ---- | ----------- | ----- |
7
+ | **target_id** | **String** | The target's Ensembl gene id (ENSG followed by eleven digits): the entry key for the targets object type. A gene symbol is not a value here; it is a separate column. | [optional] |
8
+ | **target_symbol** | **String** | The target's HGNC gene symbol (the id the target page address carries). | [optional] |
9
+ | **drug_id** | **String** | The drug's canonical id (the same id the drug datasets use as drug_id). | [optional] |
10
+ | **drug_name** | **String** | The drug's name. | [optional] |
11
+ | **authority** | **String** | The approving authority. | [optional] |
12
+ | **jurisdiction** | **String** | The authority's jurisdiction. | [optional] |
13
+ | **status** | **String** | The approval status the authority records. | [optional] |
14
+ | **first_approval_date** | **Date** | The authority's first approval date of the drug. | [optional] |
15
+ | **approval_id** | **String** | The authority's own approval identifier. | [optional] |
16
+ | **primary_action_type** | **String** | The action type of the drug's curated mechanism on the target. | [optional] |
17
+ | **moa_evidence_source** | **String** | The evidence tier of the mechanism; curated_moa on every row. | [optional] |
18
+
19
+ ## Example
20
+
21
+ ```ruby
22
+ require 'pharmaobservatory'
23
+
24
+ instance = PharmaObservatory::TargetRegulatoryPrecedentRow.new(
25
+ target_id: null,
26
+ target_symbol: null,
27
+ drug_id: null,
28
+ drug_name: null,
29
+ authority: null,
30
+ jurisdiction: null,
31
+ status: null,
32
+ first_approval_date: null,
33
+ approval_id: null,
34
+ primary_action_type: null,
35
+ moa_evidence_source: null
36
+ )
37
+ ```
38
+
@@ -0,0 +1,58 @@
1
+ # PharmaObservatory::TargetTrialsResponse
2
+
3
+ ## Properties
4
+
5
+ | Name | Type | Description | Notes |
6
+ | ---- | ---- | ----------- | ----- |
7
+ | **dataset** | **String** | | |
8
+ | **grain** | **String** | | [optional] |
9
+ | **object_type** | **String** | | [optional] |
10
+ | **id** | **String** | | [optional] |
11
+ | **scope** | [**BiomarkerAssayEvidenceResponseScope**](BiomarkerAssayEvidenceResponseScope.md) | | [optional] |
12
+ | **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
13
+ | **rows** | [**Array<TargetTrialsRow>**](TargetTrialsRow.md) | | |
14
+ | **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
15
+ | **next_cursor** | **String** | | [optional] |
16
+ | **sort** | **Array<String>** | | [optional] |
17
+ | **filters** | **Array<Hash<String, Object>>** | | [optional] |
18
+ | **group_by** | **Array<String>** | | [optional] |
19
+ | **measures** | **Array<String>** | | [optional] |
20
+ | **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
21
+ | **source_credit** | **String** | | [optional] |
22
+ | **withheld_tiers** | **Array<String>** | | [optional] |
23
+ | **withheld_columns** | **Array<String>** | | [optional] |
24
+ | **freshness** | [**BiomarkerAssayEvidenceResponseFreshness**](BiomarkerAssayEvidenceResponseFreshness.md) | | [optional] |
25
+ | **build** | [**BiomarkerAssayEvidenceResponseBuild**](BiomarkerAssayEvidenceResponseBuild.md) | | [optional] |
26
+ | **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
27
+ | **restriction** | **Hash<String, Object>** | | [optional] |
28
+
29
+ ## Example
30
+
31
+ ```ruby
32
+ require 'pharmaobservatory'
33
+
34
+ instance = PharmaObservatory::TargetTrialsResponse.new(
35
+ dataset: null,
36
+ grain: null,
37
+ object_type: null,
38
+ id: null,
39
+ scope: null,
40
+ columns: null,
41
+ rows: null,
42
+ total: null,
43
+ next_cursor: null,
44
+ sort: null,
45
+ filters: null,
46
+ group_by: null,
47
+ measures: null,
48
+ attribution: null,
49
+ source_credit: null,
50
+ withheld_tiers: null,
51
+ withheld_columns: null,
52
+ freshness: null,
53
+ build: null,
54
+ build_state: null,
55
+ restriction: null
56
+ )
57
+ ```
58
+
@@ -0,0 +1,46 @@
1
+ # PharmaObservatory::TargetTrialsRow
2
+
3
+ ## Properties
4
+
5
+ | Name | Type | Description | Notes |
6
+ | ---- | ---- | ----------- | ----- |
7
+ | **target_id** | **String** | The target's Ensembl gene id (ENSG followed by eleven digits): the entry key for the targets object type. A gene symbol is not a value here; it is a separate column. | [optional] |
8
+ | **target_symbol** | **String** | The target's HGNC gene symbol (the id the target page address carries). | [optional] |
9
+ | **trial_id** | **String** | The ClinicalTrials.gov NCT id, the id the trials datasets use. | [optional] |
10
+ | **evidence_source** | **String** | The best evidence tier among the trial's drugs that act on the target. | [optional] |
11
+ | **brief_title** | **String** | The trial's brief title. | [optional] |
12
+ | **phase** | **String** | The registry's phase code (PHASE1, PHASE2, PHASE2/PHASE3, NA and so on). Null when the registry gives no phase (observational and expanded-access trials); phase_label carries the display label for those. | [optional] |
13
+ | **phase_label** | **String** | The trial phase as a display label (Phase 2, Phase 3, Observational, Not applicable, Expanded access, Unknown). The same trial's phase column holds the registry code. | [optional] |
14
+ | **overall_status** | **String** | The registry's overall recruitment status. | [optional] |
15
+ | **start_year** | **Integer** | The year the trial started. | [optional] |
16
+ | **lead_sponsor_name** | **String** | The lead sponsor's name as filed. | [optional] |
17
+ | **lead_sponsor_org_id** | **String** | Legal-entity level: the lead sponsor organization; null when it does not resolve. | [optional] |
18
+ | **lead_sponsor_company_id** | **String** | Company level: the lead sponsor's company; null when none. | [optional] |
19
+ | **lead_sponsor_company_name** | **String** | Display name of the lead sponsor's company. | [optional] |
20
+ | **lead_sponsor_group_id** | **String** | Group level: the lead sponsor's current ultimate parent company; a root company's group is itself. | [optional] |
21
+ | **lead_sponsor_group_name** | **String** | Display name of the lead sponsor's group. | [optional] |
22
+
23
+ ## Example
24
+
25
+ ```ruby
26
+ require 'pharmaobservatory'
27
+
28
+ instance = PharmaObservatory::TargetTrialsRow.new(
29
+ target_id: null,
30
+ target_symbol: null,
31
+ trial_id: null,
32
+ evidence_source: null,
33
+ brief_title: null,
34
+ phase: null,
35
+ phase_label: null,
36
+ overall_status: null,
37
+ start_year: null,
38
+ lead_sponsor_name: null,
39
+ lead_sponsor_org_id: null,
40
+ lead_sponsor_company_id: null,
41
+ lead_sponsor_company_name: null,
42
+ lead_sponsor_group_id: null,
43
+ lead_sponsor_group_name: null
44
+ )
45
+ ```
46
+